BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 08, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a
biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today announced
Rodger Novak, M.D., Chief Executive Officer and Founder of CRISPR Therapeutics, will present at the Stifel 2016 Healthcare
Conference on Tuesday, November 15, 2016 at the Lotte New York Palace Hotel, New York.
Event: Stifel 2016 Healthcare Conference
Date: Tuesday, November 15, 2016
Time: 11:45 AM ET
A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors & Media section of the
Company's website at www.crisprtx.com.
About CRISPR Therapeutics
CRISPR Therapeutics is a leading gene-editing company focused on the development of transformative gene-based medicines for serious
diseases using its proprietary CRISPR/Cas9 gene-editing platform.
MEDIA CONTACTS: Jennifer Paganelli W2O Group for CRISPR 347-658-8290 jpaganelli@w2ogroup.com INVESTOR CONTACT: Chris Brinzey Westwicke Partners for CRISPR 339-970-2843 chris.brinzey@westwicke.com
